Lyons Michael S, Lindsell Christopher J, Fichtenbaum Carl J, Camargo Carlos A
Department of Emergency Medicine, University of Cincinnati College of Medicine, Ohio 45267-0769, USA.
Public Health Rep. 2007 Sep-Oct;122(5):579-83. doi: 10.1177/003335490712200504.
On September 22, 2006, the Centers for Disease Control and Prevention (CDC) announced recommendations to expand the role of health-care providers in human immunodeficiency virus (HIV) testing. These clearlyjustified guidelines aim to remove traditional testing barriers, and thereby increase the rate of earlier diagnosis. This overarching strategy to increase testing in all health-care settings also includes less traditional sites such as emergency departments and correctional health-care facilities. The motivation for the guidelines is intuitive, as the need for augmented testing is well supported. Of those infected with HIV in the U.S., approximately one-quarter are unaware of their disease status. People who are unaware of their infection disproportionately account for new transmissions and are unable to benefit from treatment. The HIV incidence has not fallen below approximately 40,000 new diagnoses per year, of which approximately 40% are diagnosed late in the course of infection. Universal screening, even in populations with a disease prevalence of 0.1%, has been shown to be cost-effective. While the guidelines have been reviewed in depth, current interpretations do not adequately outline a structure for further debate or facilitate incremental or partial implementation of the recommendations. This must be remedied, as comprehensive implementation of the guidelines will be controversial or logistically impossible in many settings for the foreseeable future. Herein, we provide a clarified interpretation by outlining the core guideline elements individually and within the context of current barriers to implementation. We then discuss potential combinations of the core elements that would enable increased testing in settings where comprehensive guideline implementation is not possible.
2006年9月22日,美国疾病控制与预防中心(CDC)宣布了扩大医疗服务提供者在人类免疫缺陷病毒(HIV)检测中作用的建议。这些理由充分的指南旨在消除传统检测障碍,从而提高早期诊断率。在所有医疗环境中增加检测的这一总体战略还包括急诊科和惩教医疗设施等不太传统的场所。制定这些指南的动机显而易见,因为增加检测的需求有充分依据。在美国感染HIV的人群中,约四分之一的人不知道自己的患病状况。不知道自己感染的人在新感染传播中所占比例过高,且无法从治疗中获益。HIV的年发病率一直未降至约4万例新诊断病例以下,其中约40%是在感染后期才被诊断出来的。即使在疾病患病率为0.1%的人群中进行普遍筛查,也已被证明具有成本效益。虽然这些指南已得到深入审查,但目前的解读并未充分勾勒出进一步辩论的框架,也未促进这些建议的逐步或部分实施。必须对此加以纠正,因为在可预见的未来,在许多情况下全面实施这些指南将存在争议或在后勤上无法实现。在此,我们通过分别概述核心指南要素以及在当前实施障碍的背景下进行概述,提供了一个清晰的解读。然后,我们讨论了核心要素的潜在组合,这些组合将能够在无法全面实施指南的环境中增加检测。